If the page does not redirect, click here
Breakthrough points to cure for debilitating heart and lung disease
A protein that targets the effects of a faulty gene could offer the first treatment targeting the major genetic cause of Pulmonary Arterial Hypertension (PAH), according to research funded by the British Heart Foundation (BHF).